← Retour à la une
Asie · Marchés régionaux · CNBC-TV18

Hospital stocks: Max Healthcare, Fortis, Aster DM lead gains after recent sell-off

Publié par CNBC-TV18 · Inde il y a 33 min
Hospital stocks: Max Healthcare, Fortis, Aster DM lead gains after recent sell-off - CNBC TV18
Hospital stocks: Max Healthcare, Fortis, Aster DM lead gains after recent sell-off - CNBC TV18 · CNBC-TV18

Résumé détaillé

Among the stocks, Max Healthcare was the top gainer, trading 5.90% up at ₹1,000.75 around 1.15 pm. Fortis Healthcare advanced 4.54% to ₹798.65, while Aster DM Healthcare gained…

Shares of major hospital chains rose sharply on Monday, November 16, with Max Healthcare, Apollo Hospitals, Fortis Healthcare and Aster DM gaining between 2% and 6%.

The gains come after a recent sell-off in hospital stocks, triggered by concerns over potential regulatory intervention in healthcare pricing. However, some market participants see the correction as a buying opportunity, arguing that India's structural shortage of hospital beds and rising demand continue to support the sector's long-term growth prospects.

Among the stocks, Max Healthcare was the top gainer, trading 5.90% up at ₹1,000.75 around 1.15 pm. Fortis Healthcare advanced 4.54% to ₹798.65, while Aster DM Healthcare gained 4.42% to ₹754.40. Apollo Hospitals was up 2.40% at ₹8,730.50.

The recent weakness in the sector followed concerns around possible regulatory intervention in healthcare pricing. In September, the Supreme Court also questioned the Centre on the possibility of applying a uniform 16% markup across medicines, while raising concerns over pricing practices at corporate hospitals, including the requirement for patients to buy medicines from in-house pharmacies or specified chemists.

The regulatory scrutiny has added to concerns about the potential impact on hospital profitability. However, last month, Aditya Khemka, Fund Manager at InCred, said he believes the correction could offer an attractive entry point for investors.

Khemka said previous episodes of price regulation in 2017 and 2019, involving stents, knee implants and certain medicines, had eventually presented buying opportunities.

“Hospital prices corrected proved to be a phenomenal entry point. Seems like it's a repeat of the cycle,” he said.

According to Khemka, hospitals operate as platform businesses, bringing patients and doctors together while providing the required infrastructure.

He said hospitals could adjust prices across other parts of their service offerings if regulators impose margin caps on specific segments.

Début de l'article, extrait de CNBC-TV18. Pour lire la suite, ouvrez l'article chez le média.

Lire l'article complet sur CNBC-TV18 Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.cnbctv18.com)

À lire aussi